首页> 外国专利> Phthalazinone derivatives substituted 5-membered heterocyclic aryl, or pharmaceutically acceptable salts thereof, preparation method therof and pharmaceutical composition

Phthalazinone derivatives substituted 5-membered heterocyclic aryl, or pharmaceutically acceptable salts thereof, preparation method therof and pharmaceutical composition

机译:酞嗪酮衍生物取代的五元杂环芳基或其药学上可接受的盐,其制备方法和药物组合物

摘要

5- ring heteroaryl substituted by Tala profile Xenon derivatives, their preparation , and it includes , as an active ingredient, which provides a pharmaceutical composition . Xenon by phthalazine derivatives substituted 5- ring heteroaryl group according to the invention act as antagonists for MCH ( melanin concentrating hormone ) receptor is induced by obesity MCH binding to the MCH receptor-1 , diabetes , metabolic disorders , anxiety and can be used , such as depression and related disorders MCH receptor-1 is useful for preventing or treating .
机译:Tala轮廓氙衍生物取代的5环杂芳基,它们的制备方法,它包括作为有效成分的药物组合物。通过肥胖症的MCH与MCH受体-1的结合,糖尿病,代谢紊乱,焦虑而诱导的,被本发明的酞菁氙取代的5-环杂芳基的氙作为MCH(黑色素浓缩激素)受体的拮抗剂而可以使用,例如作为抑郁症和相关疾病的MCH受体1可用于预防或治疗。

著录项

  • 公开/公告号KR101242572B1

    专利类型

  • 公开/公告日2013-03-19

    原文格式PDF

  • 申请/专利权人

    申请/专利号KR20100099348

  • 发明设计人 서무영;임채조;송석진;이규양;

    申请日2010-10-12

  • 分类号C07D409/14;C07D405/14;A61K31/502;A61P3/00;

  • 国家 KR

  • 入库时间 2022-08-21 16:25:32

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号